Transcriptional activation of insulin-like growth factor binding protein 6 by 17β-estradiol in SaOS-2 cells

Experimental and Molecular Medicine

Volumn 41, Issue 7, 2009, Pages 478-486

  Zhao, Yu Yan ^a   Guo, Lei ^a   Zhao, Xiao Juan ^a   Liu, Hong ^a   Lei, Tian ^a   Ma, Dong Jie ^a   Gao, Xiao Yu ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Estrogen; Insulin like growth factor binding protein 6; Osteoblasts; Receptors, estrogen; Transcription, genetic

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; ESTRADIOL; ESTROGEN RECEPTOR; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 6;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; GENE SEQUENCE; GENETIC TRANSCRIPTION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; PROMOTER REGION; TRANSCRIPTION INITIATION;

EID: 68049115753     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2009.41.7.053     Document Type: Article

References (48)

1. Arts J, Kuiper GG, Janssen JM, Gustafsson JA, Löwik CW, Pols HA, van Leeuwen JP.Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells. Endocrinology 1997;138:5067-5070 (Pubitemid 27460951)
2. Bach LA, Hsieh S, Brown AL, Rechler MM. Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts. Endocrinology 1994;135:2168-2176 (Pubitemid 24363916)
3. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG.Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 2003;89:1235-1249 (Pubitemid 36959389)
4. Bienvenu G, Seurin D, Grellier P, Froment P, Baudrimont M, Monget P, Le Bouc Y, Babajko S. Insulin-like growth factor binding protein-6 transgenic mice: postnatal growth, brain development, and reproduction abnormalities. Endocrinology 2004;145:2412-2420 (Pubitemid 38535070)
5. Bodine PV, Henderson RA, Green J, Aronow M, Owen T, Stein GS, Lian JB, Komm BS.Estrogen receptor-alpha is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression. Endocrinology 1998;139:2048-2057 (Pubitemid 28513868)
6. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248-254
7. Brockdorff BL, Heiberg I, Lykkesfeldt AE. Resistance to different antiestrogens is caused by different multi-factorial changes and is associated with reduced expression of IGF receptor Ialpha. Endocr Relat Cancer 2003;10:579-590 (Pubitemid 38094892)
8. Brown TJ, Hochberg RB, Zielinski JE, MacLusky NJ. Regional sex differences in cell nuclear estrogen-binding capacity in the rat hypothalamus and preoptic area. Endocrinology 1988;123:1761-1770
9. Cesario RM, Stone J, Yen WC, Bissonnette RP, Lamph WW. Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer. Cancer Lett 2006;240:225-233 (Pubitemid 44093823)
10. Cummings AM, Laws SC.Assessment of estrogenicity by using the delayed implanting rat model and examples. Reprod Toxicol 2000;14:111-117
11. Dailly YP, Zhou Y, Linkhart TA, Baylink DJ, Strong DD. Structure and characterization of the human insulin-like growth factor binding protein (IGFBP)-6 promoter: identification of a functional retinoid response element. Biochim Biophys Acta 2001;1518:145-151 (Pubitemid 32232287)
12. Dake BL, Boes M, Bach LA, Bar RS. Effect of an insulin-like growth factor binding protein fusion protein on thymidine incorporation in neuroblastoma and rhabdomyosarcoma cell lines. Endocrinology 2004;145:3369-3374 (Pubitemid 38830009)
13. Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988;241:84-86
14. Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895
15. Fu P, Thompson JA, Bach LA. Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6. J Biol Chem 2007;282:22298-22306 (Pubitemid 47267353)
16. Gallicchio MA, Kaun C, Wojta J, Binder B, Bach LA. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro. J Cell Physiol 2003;197:131-138 (Pubitemid 37486235)
17. Gielen SC, Hanekamp EE, Hanifi-Moghaddam P, Sijbers AM, van Gool AJ, Burger CW, Blok LJ, Huikeshoven FJ. Growth regulation and transcriptional activities of estrogen and progesterone in human endometrial cancer cells. Int J Gynecol Cancer 2006;16:110-120
18. Green S, Chambon P.Nuclear receptors enhance our understanding of transcription regulation. Trends Genet 1988;4:309-314 (Pubitemid 18270497)
19. Grellier P, De Galle B, Babajko S. Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. Cancer Res 1998;58:1670-1676 (Pubitemid 28215091)
20. Guo L, Zhao YY, Dong LY, Ding Q, Sun KL, Ji SJ, Wang LZ. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the gene expression of insulin-like growth factors family in osteoblast cells.Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2003;20:490-494
21. Guo L, Zhao YY, Zhao YY, Sun ZJ, Liu H, Zhang SL. Toxic effects of TCDD on osteogenesis through altering IGFBP-6 gene expression in osteoblasts. Biol Pharm Bull 2007;30:2018-2026 (Pubitemid 350097032)
22. Hodzic D, Delacroix L, Willemsen P, Bensbaho K, Collette J, Broux R, Lefèbvre P, Legros JJ, Grooteclaes M, Winkler R. Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma. Horm Metab Res 1997;29:549-555 (Pubitemid 28053665)
23. Hondermarck H. Breast cancer: when proteomics challenges biological complexity. Mol Cell Proteomics 2003;2:281-291
24. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34
25. Kallio A, Guo T, Lamminen E, Seppänen J, Kangas L, Vään̈nen HK, Ḧrk̈nen P. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells. Mol Cell Endocrinol 2008;289:38-48
26. Kim EJ, Kang YH, Schaffer BS, Bach LA, MacDonald RG, Park JH. Inhibition of Caco-2 cell proliferation by all-trans retinoic acid: role of insulin-like growth factor binding protein-6.J Cell Physiol 2002;190:92-100
27. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW, Haussler MR. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 1988;241:81-84 (Pubitemid 18168119)
28. Kuntz MA, Shapiro DJ. Dimerizing the estrogen receptor DNA binding domain enhances binding to estrogen response elements. J Biol Chem 1997;272:27949-27956 (Pubitemid 27473600)
29. Lima F, Vico L, Lafage-Proust MH, van der Saag P, Alexandre C, Thomas T. Interactions between estrogen and mechanical strain effects on U2OS human osteosarcoma cells are not influenced by estrogen receptor type. Bone 2004;35:1127-1135 (Pubitemid 39487359)
30. Ma WG, Song H, Das SK, Paria BC, Dey SK.Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation.Proc Natl Acad Sci U S A 2003;100:2963-2968
31. Martin JL, Coverley JA, Pattison ST, Baxter RC. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. Endocrinology 1995;136:1219-1226
32. Milne M, Quail JM, Rosen CJ, Baran DT.Insulin-like growth factor binding proteins in femoral and vertebral bone marrow stromal cells: expression and regulation by thyroid hormone and dexamethasone.Department of Orthopedics and Physical Rehabilitation. J Cell Biochem 2001;81:229-240
33. Nardulli AM, Romine LE, Carpo C, Greene GL, Rainish B. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. Mol Endocrinol 1996;10:694-704 (Pubitemid 26176277)
34. Nautiyal J, Kumar PG, Laloraya M. 17Beta-estradiol induces nuclear translocation of CrkL at the window of embryo implantation. Biochem Biophys Res Commun 2004;318:103-112 (Pubitemid 38526251)
35. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem 1996;271:30322-30325 (Pubitemid 26404030)
36. Orimo A, Inoue S, Ikegami A, Hosoi T, Akishita M, Ouchi Y, Muramatsu M, Orimo H.Vascular smooth muscle cells as target for estrogen. Biochem Biophys Res Commun 1993;195:730-736 (Pubitemid 23280477)
37. Partridge NC, Fiacco GJ, Walling HW, Barmina OY, Jeffrey JJ, Ruh MF. Effects of dioxin and estrogen on collagenase-3 in UMR 106-01 osteosarcoma cells.Arch Biochem Biophys 2000;382:182-188
38. Salahifar H, Baxter RC, Martin JL. Differential regulation of insulin-like growth factor-binding protein-3 protease activity in MCF-7 breast cancer cells by estrogen and transforming growth factor-beta1. Endocrinology 2000;141:3104-3110 (Pubitemid 32268997)
39. Schmid C, Keller C, Gosteli-Peter M, Zapf J. Mitogenic and antiapoptotic effects of insulin-like growth factor binding protein-6 in the human osteoblastic osteosarcoma cell line Saos-2/B-10. Biochem Biophys Res Commun 1999;263:786-789 (Pubitemid 29490705)
40. Seurin D, Lassarre C, Bienvenu G, Babajko S. Insulin-like growth factor binding protein-6 inhibits neuroblastoma cell proliferation and tumour development. Eur J Cancer 2002;38:2058-2065
41. Simerly RB, Chang C, Muramatsu M, Swanson LW. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 1990;294:76-95 (Pubitemid 20104631)
42. Song BL, Qi W, Yang XY, Chang CC, Zhu JQ, Chang TY, Li BL. Organization of human ACAT-2 gene and its celltype- specific promoter activity. Biochem Biophys Res Commun 2001;282:580-588 (Pubitemid 32917911)
43. Spelsberg TC, Subramaniam M, Riggs BL, Khosla S.The actions and interactions of sex steroids and growth factors/cytokines on the skeleton.Mol Endocrinol 1999;13:819-828
44. Strohbach C, Kleinman S, Linkhart T, Amaar Y, Chen ST, Mohan S, Strong D. Potential involvement of the interaction between insulin-like growth factor binding protein (IGFBP)-6 and LIM mineralization protein (LMP)-1 in regulating osteoblast differentiation. J Cell Biochem 2008;104:1890-1905
45. Stumpf WE, Sar M, Aumüller G.The heart: a target organ for estradiol. Science 1977;196:319-321
46. Sueoka N, Lee HY, Walsh GL, Fang B, Ji L, Roth JA, LaPushin R, Hong WK, Cohen P, Kurie JM. Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abundance with all-transretinoic acid treatment. Am J Respir Cell Mol Biol 2000;23:297-303 (Pubitemid 30701838)
47. Sueoka N, Lee HY, Wiehle S, Cristiano RJ, Fang B, Ji L, Roth JA, Hong WK, Cohen P, Kurie JM. Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells. Oncogene 2000;19:4432-4436 (Pubitemid 30744373)
48. Yan T, Wergedal J, Zhou Y, Mohan S, Baylink DJ, Strong DD. Inhibition of human osteoblast marker gene expression by retinoids is mediated in part by insulin-like growth factor binding protein-6. Growth Horm IGF Res 2001;11:368-377 (Pubitemid 34428880)